Skip to main content

Volume 13 - Issue 1 - January 2016

January 2016 Issue 1 Volume 13

Interview by Jennifer Ford
Cynthia Shortell, MD, chief of vascular surgery at Duke University Medical Center, speaks with Vascular Disease Management about trends in CLI therapy today.

Interview by Jennifer Ford

At the 2015 VEITH Symposium, Vascular Disease Management spoke with Lowell Kabnick, MD, and Jose Almeida, MD, co-chairs of the venous programming at the meeting. They describe the pros and cons related to the ways that clinicians from multiple specia…

Interview by Jennifer Ford

At the 2015 VIVA meeting, data were presented from a study investigating economic impact of various endovascular interventions compared to the Supera stent from Abbott Vascular. Vascular Disease Management spoke with Brian G. DeRubertis, MD, about de…
New Technique

Larry E. Miller, PhD1; Richard Kovach, MD2; Robert Beasley, MD3; Jeffrey A. Goldstein, MD4; Hailey Austin5; Blaine A. Schneider, PhD5

From 1Miller Scientific Consulting, 2Deborah Heart and Lung Center, 3Mount Sinai Heart Institute, 4Prairie Cardiovascular Consultants, and 5The Spectranetics Corporation.

The authors describe the procedural technique of excimer laser atherectomy within in-stent restenosis and to highlight the clinical utility of this technology in challenging case examples.
Original Research

Anvar Babaev, MD, PhD; Pawan Hari, MD; Susanna Zavlunova, MD; Anna Kurayev, MD

From New York University Langone Medical Center, New York, New York.

Stent fractures in the SFA play a modest role in the development of in-stent restenosis. In this study, a majority of patients with in-stent restenosis did not have stent fracture.
Editor's Corner

Amjad AlMahameed, MD, MPH; Craig Walker, MD

Despite new technologies and research, stent fracture continues to be a challenge faced by vascular specialists. 
Back to Top